Form 8-K ORTHOFIX INTERNATIONAL For: Nov 02

�

�

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

�

�

FORM 8-K

CURRENT REPORT

Pursuant to Section�13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November�2, 2014

�

�

Orthofix International N.V.

(Exact name of Registrant as specified in its charter)

�

Cura�ao	�	0-19961	�	N/A
(State or other jurisdiction of incorporation)	�	(Commission File Number)	�	(IRS Employer Identification No.)

�

7 Abraham de Veerstraat Cura�ao	�	N/A
(Address of principal executive offices)	�	(Zip Code)

�

�

Registrant�s telephone number, including area code: 011-59-99-465-8525

�

�

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

�

�	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

�

�	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

�

�	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

�

�	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

�

�

�

---

Item�5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Retirement of Kathleen Regan

The Board of Directors (the �Board�) of Orthofix International N.V. (the �Company�) previously announced the retirement of Kathleen Regan from the Board, effective as of November�3, 2014, as well as the reduction in the size of the Board as of such date from nine to eight directors. Ms.�Regan has now requested that her retirement be effective as of January�4, 2015, and the Board has approved such request. As of such date, Ms.�Regan�s retirement shall be effective, and the size of the Board shall be decreased from nine to eight directors. As the Company has previously disclosed, Ms.�Regan�s retirement is not related to any disagreement with the Company or the Board regarding any matter related to the Company�s operations, policies or practices. As of Ms.�Regan�s retirement, Ronald Matricaria will succeed her as Chair of the Board�s Nominating and Governance Committee.

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

�

Date: November�3, 2014

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
• TANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
• ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Compass Minerals International, Inc. Investors to Inquire About Securities Class Action Investigation – CMP